Evotec SE (EVOTF)
OTCMKTS · Delayed Price · Currency is USD
8.52
-0.06 (-0.75%)
At close: Jul 18, 2025
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.43 billion as of August 1, 2025. Its market cap has decreased by -16.93% in one year.
Market Cap
1.43B
Enterprise Value
1.55B
Revenue
851.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
$8.52
Market Cap Chart
Since November 11, 1999, Evotec SE's market cap has increased from 4.65M to 1.43B, an increase of 30,537.16%. That is a compound annual growth rate of 24.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.43B | -5.47% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | 6.08B | 56.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |